期刊文献+

“质量源于设计”在拉考沙胺注射液处方工艺研究中的应用 被引量:1

Application of “Quality by Design” in the Formulation and Process Research of Lacosamide Injection
下载PDF
导出
摘要 基于“质量源于设计”(quality by design,QbD)理念,对拉考沙胺注射液的质量概况(QTPP)、关键质量属性(CQA)进行研究、基于关键物料属性(CMA)等方面对处方工艺变量进行了风险评估,制定了溶液 pH 值的控制策略。 Based on the concept of“quality by design (QbD)”,the sources of quality risks in Lacosamide injection were analyzed;“quality target product profile (QTPP)”and the“critical quality attributes (CQA)”of injections were discussed.The risks of injection formulation and process variables were analyzed,Developed a strategy to control the pH of the solution.
作者 殷华峰 欧阳婷 Yin Huafeng;Ouyang Ting(Jiangxi Qingfeng Pharmaceutical Co.,Ltd.,Ganzhou 341000,China)
出处 《广东化工》 CAS 2019年第24期142-144,共3页 Guangdong Chemical Industry
关键词 质量源于设计 拉考沙胺注射液 处方工艺研究 应用 quality by design(QbD) Lacosamide injection formulation and process research application
  • 相关文献

参考文献1

二级参考文献9

  • 1ICH.QSpharmaceuticaldevelopment[S]//药品注册的国际技术要求(质量部分),周海钧主译,北京:人民卫生出版社,2006.
  • 2ICH.Q8(R2)pharmaceuticaldevelopment[S]//药品注册的国际技术要求(质量部分),周海钧主译,北京:人民卫生出版社,2011.
  • 3ICH.Q9RualityRiskManagement[S]//药品注册的国际技术要求(质量部分).周海钧主译,北京:人民卫生出版社,2006.
  • 4ICH.QIOPharmaceuticalQualitySystem[S]//药品注册的国际技术要求(质量部分),周海钧主译,北京:人民卫生出版社,2011.
  • 5FDA. Quality by design for ANDAs: an example for modified re- lease dosage forms [ EB/OL ]. ( 2011 - 12 ). http ://www. fda. gov/ downloads/drugs/developmentapprov alprocess/houdrgsaredevelope- dandapproved/approvalapplications/abbreciatednewd*ugapplication- andagenerics/uem286595, pdf.
  • 6FDA. Quality by design for ANDAs: an example for modified re- lease dosage forms [ EB/OL ]. ( 2012 - 4 ). http ://ww w. fda. gov/ downloads/ drugs/ developmentapprovalproeess/ houdrgsaredevelo- pedandapproved/approvalapplieations/abbreeiatednewdrugappliea- tionandageneries/uem304305, pdf.
  • 7FDA. FDA Issues Warning Letters to Ranbaxy Laboratories Ltd. , and an import alert for drugs from two ranbaxy plants in India[ EB/ OL ]. ( 2008 ). http://www, fda, gov/newsevents/newsroom/pres- sannoucements/2OOS/ucm116949, htm.
  • 8陈彬华,文彬.QbD理念在药品研发、生产、质量控制过程中的应用[J].上海医药,2008,29(10):446-447. 被引量:21
  • 9韩亮,Nicholas Buhay,郑强.美国FDA药品生产质量监管体系[J].中国新药杂志,2012,21(18):2128-2136. 被引量:16

共引文献25

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部